EQS-News: Steyr Motors AG / Key word(s): Annual Report/Annual Results Steyr Motors publishes Annual Report 2024 – Forecast achieved, strong growth with high profitability expected in the 2025 financial year 18.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Steyr Motors publishes Annual Report 2024 – Forecast achieved, strong growth with high profitability expected in the 2025 financial year Adjusted EBIT multiplied to EUR 10.1 million (previous year: EUR 3.6 million) Adjusted EBIT margin of 24.3% achieved (previous yea...
EQS-News: Instone Real Estate Group SE / Schlagwort(e): Jahresergebnis Instone Group erreicht sämtliche Jahresziele; für 2025 wird deutliche Belebung der Nachfrage erwartet 18.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Instone Group erreicht sämtliche Jahresziele; für 2025 wird deutliche Belebung der Nachfrage erwartet Bereinigte Umsatzerlöse von 527,2 Millionen Euro im Jahr 2024 (2023: 616,0 Millionen Euro) mit planmäßiger Entwicklung Weiterhin hohe bereinigte Rohergebnismarge von 22,6 Prozent (2023: 25,1 Proz...
EQS-News: Steyr Motors AG / Schlagwort(e): Jahresbericht/Jahresergebnis Steyr Motors veröffentlicht Geschäftsbericht 2024 – Prognosen erreicht, starkes Wachstum bei hoher Profitabilität im Geschäftsjahr 2025 erwartet 18.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Steyr Motors veröffentlicht Geschäftsbericht 2024 – Prognosen erreicht, starkes Wachstum bei hoher Profitabilität im Geschäftsjahr 2025 erwartet Bereinigtes EBIT auf EUR 10,1 Mio. vervielfacht (Vorjahr: EUR 3,6 Mio.) Bereinigte EBIT-Marge von 24,3 % erre...
EQS-News: Instone Real Estate Group SE / Key word(s): Annual Results Instone Group achieves all full year targets; demand expected to pick up significantly in 2025 18.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Instone Group achieves all full year targets; demand expected to pick up significantly in 2025 Adjusted revenues of EUR 527.2 million in 2024 (2023: EUR 616.0 million) in line with expectations Continued high adjusted gross profit margin of 22.6 per cent (2023: 25.1 per cent) provides further evidence of the qu...
EQS-News: EXASOL AG / Schlagwort(e): Jahresergebnis/Jahresbericht Exasol veröffentlicht Geschäftsbericht 2024 – Testierte Zahlen im Rahmen der vorläufigen Ergebnisse und Prognose 18.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Exasol veröffentlicht Geschäftsbericht 2024 – Testierte Zahlen im Rahmen der vorläufigen Ergebnisse und Prognose EBITDA steigt auf 2,0 Mio. Euro, positives Konzernergebnis von 0,2 Mio. Euro Starkes Wachstum von 19 % in den Fokus-Branchen unterstreicht strategische Ausrichtung auf on-premis...
EQS-News: SFC Energy AG / Key word(s): Incoming Orders SFC Energy AG receives follow-up order worth more than CAD 5 million from long-standing Canadian Government customer for EFOY fuel cells and SFC power solutions 18.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. SFC Energy AG receives follow-up order worth more than CAD 5 million from long-standing Canadian Government customer for EFOY fuel cells and SFC power solutions Brunnthal/Munich, Germany, 18 March 2025 – SFC Energy AG (“SFC”, , ISIN: ), a leading provider of hyd...
EQS-News: SFC Energy AG / Schlagwort(e): Auftragseingänge SFC Energy AG erhält Folgeauftrag von mehr als CAD 5 Mio. von langjährigem kanadischen Regierungskunden für EFOY Brennstoffzellen und SFC Stromversorgungslösungen 18.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SFC Energy AG erhält Folgeauftrag von mehr als CAD 5 Mio. von langjährigem kanadischen Regierungskunden für EFOY Brennstoffzellen und SFC Stromversorgungslösungen Brunnthal/München, Deutschland, 18. März 2025 – Die SFC Energy AG („SFC“, , ISIN: ), ein...
EQS-News: EXASOL AG / Key word(s): Annual Results/Annual Report Exasol publishes 2024 Annual Report – Audited figures in line with preliminary results and forecast 18.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Exasol publishes 2024 Annual Report – Audited figures in line with preliminary results and forecast EBITDA rises to EUR 2.0 million, positive consolidated net income of EUR 0.2 million Strong growth of 19% in key sectors emphasizes strategic focus on on-premise and hybrid solutions Guidance 2025 confirmed: EB...
Two Directors at Rambus Inc sold 11,376 shares at between 52.975USD and 53.270USD. The significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Šiaulių banko pateikiama informacija internetiniame seminare apie prekių ženklo atnaujinimą Šiaulių banko Administracijos vadovas Vytautas Sinius ir Rinkodaros ir komunikacijos departamento vadovė Raimonda Gudaitė pristatys Banko prekių ženklo atnaujinimą. Pridedame informaciją, kuri bus pateikiama seminaro metu. Papildoma informacija:Tomas Varenbergas Investicijų valdymo tarnybos vadovas Priedas
Information to be delivered by Šiaulių Bankas at the Investor Conference Webinar on Rebranding will be hosted by Vytautas Sinius, CEO and Raimonda Gudaitė, CMO, who will introduce the Rebranding of the Bank. Please find enclosed the information to be delivered during the presentation. Additional information:Tomas VarenbergasHead of Investment Management Division Attachment
Transaction in Own Shares ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 18 March 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase: 17 March 2025 Aggregate number of ordinary shares of USD 0.01 each purchased: 31,000 Lowest price paid per share (GBp): 1,675.00 Highest price paid per share (GBp): 1,695.00 Volume weighted average price paid per share (GBp): 1,68...
Cabka shows resilience in 2024 despite challenging markets PRESS RELEASE Online investor presentation and Q&A at 10.30 CET on 18 March 2025 via: Amsterdam, Netherlands - 18 March 2025 - Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext Amsterdam, announces its preliminary non-audited 2024 full year results. Cabka shows resilience in 2024 despite challenging markets Key financial developments 2024 Sales of €181.9 million, 8...
We initiate coverage of Diagnostyka with a BUY rating and a 12M price target (PT) of PLN 159/share. Diagnostyka is the leader of the Polish medical diagnostics market, with a 22% share in the total addressable medical laboratory testing market and 49% in the private segment. Operating in the hub-and-spoke model, the company combines economies of scale with superior proximity and attractive prices. By 2028E, Diagnostyka’s management expects to double its sales, outperforming Bain and Co.’s market...
A director at Maridive & Oil Services bought 457,891 shares at 0.000USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Two Directors at Mena Tourism & Real Estate Investment bought/sold 427,474 shares at 0.000EGP. The significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
A director at Amicogen Inc bought 8,300 shares at 3,627.000KRW and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
A director at Harford Bank of Aberdeen bought 1,500 shares at 34.000USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
EQS-News: HomeToGo SE / Key word(s): Personnel HomeToGo extends Co-founder & CEO Dr. Patrick Andrae’s contract by four years 18.03.2025 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. HomeToGo extends Co-founder & CEO Dr. Patrick Andrae’s contract by four years Luxembourg, 18 March 2025 - HomeToGo SE (Frankfurt Stock Exchange: HTG), the SaaS-enabled marketplace with the world’s largest selection of vacation rentals, today announced that HomeToGo Co-founder Dr. Patrick Andrae will continue to lead the HomeToGo Group in his role as C...
PolyPeptide Group / Key word(s): AGMEGM PolyPeptide publishes invitation to the annual General Meeting 2025 18.03.2025 / 07:00 CET/CEST Media release PolyPeptide publishes invitation to the annual General Meeting 2025 Baar, 18 March 2025 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, published today the invitation to the fourth annual General Meeting, which will take place on 9 April 2025 at the Chollerhalle in Zug. At PolyPeptide Group AG’s (the “Company”) fourth annual General Meeting, which will take place...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.